Search

Susan P Weinbach

from San Diego, CA
Age ~60
Get Report
Also known as:
Susan Pennie Weinbach, Susan Weinbach Reingold, Susan W Reingold, Susan P Weibach, Bach Reingold N
Phone and address:
12974 Carmel Creek Rd UNIT 184, San Diego, CA 92130
(858) 356-9677
Related to:
Kristen M Weinbach, 52Kurt WeinbachJonathan L Reingold, 63Sheila G Weinbach, 87Julie C Weinbach, 65Leonard A Reingold, 63James L Reingold, 55Karen S Criddle, 63
Connected to:
Lawrence P Weinbach, 91Chad E Weinbaum, 49Elan R Weinbaum, 48Eliezer D Weinbaum, 66Joel Weinbaum, 79Kerry G Weinbaum, 72Laurence Weinbaum, 62Marsha L Weinbaum, 83Neil D Weinbaum, 59Scott M Weinbaum, 37

Susan Weinbach Phones & Addresses

  • 12974 Carmel Creek Rd UNIT 184, San Diego, CA 92130 (858) 356-9677
  • 4435 Nobel Dr, San Diego, CA 92122
  • 1C Clintwood Dr, Rochester, NY 14620 (716) 442-1413
  • Goleta, CA

Work

Company: Celgene Jul 2018 Position: Director of regulatory affairs

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Weizmann Institute of Science 1988 to 1995 Specialities: Chemistry

Skills

Fda • Ectd • Biologics • Combination Products • Ctd • Impd • Emea

Industries

Biotechnology

Resumes

Resumes

Susan Weinbach Photo 1

Director Of Regulatory Affairs

View page
Location:
6046 Cornerstone Ct west, San Diego, CA 92121
Industry:
Biotechnology
Work:
Celgene
Director of Regulatory Affairs
Conventus Biomedical Solutions, Inc. Jan 2017 - Jul 2018
Director of Regulatory Affairs
Conventus Biomedical Solutions, Inc. Nov 2013 - Dec 2016
Associate Director Regulatory Affairs
Advanced Biohealing Apr 2012 - Nov 2013
Associate Director Regulatory Affairs
Advanced Biohealing Aug 2009 - Apr 2012
Regulatory Affairs Project Leader
Education:
Weizmann Institute of Science 1988 - 1995
Doctorates, Doctor of Philosophy, Chemistry Princeton University 1985 - 1987
Masters, Master of Arts, Chemistry Oberlin College 1982 - 1985
Bachelors, Bachelor of Arts, Chemistry Oberlin College
Bachelors Princeton University
Masters
Skills:
Fda
Ectd
Biologics
Combination Products
Ctd
Impd
Emea

Publications

Us Patents

Antisense Permeation Enhancers

View page
US Patent:
8039444, Oct 18, 2011
Filed:
Aug 23, 2006
Appl. No.:
11/509529
Inventors:
Araz A. Raoof - Dublin, IE
Mangaraju Gudipati - Yardley PA, US
David C. Bibby - Emeryville CA, US
Susan Weinbach - San Diego CA, US
Assignee:
Isis Pharmaceuticals, Inc. - Carlsbad CA
International Classification:
A61K 48/00
A61K 31/20
US Classification:
514 44A, 514558, 536 25
Abstract:
A pharmaceutical composition comprising an antisense oligonucleotide and a permeation enhancer that comprises a multi-carbon backbone having a functional group and also one or more side chains which have one or more carbon atoms and, optionally, one or more functional groups.

Pulsatile Release Compositions And Methods For Enhanced Intestinal Drug Absorption

View page
US Patent:
20030124196, Jul 3, 2003
Filed:
Aug 22, 2001
Appl. No.:
09/944493
Inventors:
Susan Weinbach - San Diego CA, US
Lloyd Tillman - Carlsbad CA, US
Richard Geary - Carlsbad CA, US
Gregory Hardee - Rancho Santa Fe CA, US
International Classification:
A61K048/00
A61K009/50
US Classification:
424/499000, 514/044000
Abstract:
Delayed release oral pharmaceutical formulations and methods for enhanced intestinal drug absorption. The formulation comprises a first population of carrier particles comprising a drug and a penetration enhancer which are released at a first location in the intestine, and a second population of carrier particles comprising a penetration enhancer and a delayed release coating or matrix. This penetration enhancer is released at a second location in the intestine downstream from the first location and enhances absorption of the drug when it reaches the second location.

Pulsatile Release Compositions And Methods For Enhanced Intestinal Drug Absorption

View page
US Patent:
20050196443, Sep 8, 2005
Filed:
Dec 1, 2004
Appl. No.:
11/000814
Inventors:
Susan Weinbach - San Diego CA, US
Lloyd Tillman - Oceanside CA, US
Richard Geary - Carlsbad CA, US
Gregory Hardee - Carlsbad CA, US
Assignee:
ISIS Pharmaceuticals, Inc. - Carlsbad CA
International Classification:
A61K048/00
A61K009/26
US Classification:
424469000, 514044000
Abstract:
Delayed release oral pharmaceutical formulations and methods for enhanced intestinal drug absorption. The formulation comprises a first population of carrier particles comprising a drug and a penetration enhancer which are released at a first location in the intestine, and a second population of carrier particles comprising a penetration enhancer and a delayed release coating or matrix. This penetration enhancer is released at a second location in the intestine downstream from the first location and enhances absorption of the drug when it reaches the second location.

Pulsatile Release Compositions And Methods For Enhanced Intestinal Drug Absorption

View page
US Patent:
20110256217, Oct 20, 2011
Filed:
Jun 16, 2009
Appl. No.:
12/485675
Inventors:
Susan Weinbach - San Diego CA, US
Lloyd G. Tillman - Encinitas CA, US
Richard S. Geary - Carlsbad CA, US
Gregory E. Hardee - Del Mar CA, US
Assignee:
Isis Pharmaceuticals, Inc. - Carlsbad CA
International Classification:
A61K 9/14
A61K 31/712
A61K 9/22
A61K 9/28
A61K 31/7088
A61K 9/52
US Classification:
424452, 424490, 514 44 R, 514 44 A, 424465
Abstract:
Delayed release oral pharmaceutical formulations and methods for enhanced intestinal drug absorption. The formulation comprises a first population of carrier particles comprising a drug and a penetration enhancer which are released at a first location in the intestine, and a second population of carrier particles comprising a penetration enhancer and a delayed release coating or matrix. This penetration enhancer is released at a second location in the intestine downstream from the first location and enhances absorption of the drug when it reaches the second location.
Control profile
Susan P Weinbach from San Diego, CA, age ~60 Get Report